Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04493827 Completed - Clinical trials for Adenocarcinoma of Lung Stage IV

Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center

Start date: January 2011
Phase:
Study type: Observational

The recent discovery of oncogenic drivers has revolutionized the management of advanced lung cancer by development of tyrosine kinase inhibitors targeted therapies. Prevalence of daily tobacco use is evaluated at 31,3 % in Grand-Est region, the only French region with a statistically significative difference for smoking habits. This region shows a higher incidence (+ 13 %) and mortality for lung cancer in comparison to the average for other French regions. The objectives of our studie were to estimate the distribution of oncogenic drivers and analyse their prognostic impacts in the Nancy University Hospital Center metastatic lung adenocarcinoma's population.

NCT ID: NCT04493671 Completed - Tuberculosis Clinical Trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Start date: June 8, 2020
Phase: Phase 1
Study type: Interventional

A Phase 1, Partially Blind, Placebo Controlled, Randomized, Combined Single Ascending Dose with a Food Effect Cohort (Part 1) and Multiple Ascending Dose Study (Part 2) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBAJ-876 in Healthy Adult Subjects

NCT ID: NCT04492956 Completed - Clinical trials for Childhood-Onset Fluency Disorder (Stuttering)

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

Start date: October 2, 2020
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 exploratory study in adult subjects with childhood onset fluency disorder.

NCT ID: NCT04492839 Completed - Clinical trials for Gastroesophageal Reflux

Intestinal Adsorbent and Breath Gas Levels

Start date: August 13, 2019
Phase: N/A
Study type: Interventional

To determine the effect of an intestinal adsorbent on hydrogen and methane breath levels in patients who have been on long term PPI therapy reporting reflux and abdominal symptoms at baseline.

NCT ID: NCT04492332 Completed - Clinical trials for Intracranial Hypertension

Influencing Factors of Intracranial Hypertension in Patients With Bilateral Transverse Sinus Stenosis

Start date: January 2014
Phase: N/A
Study type: Interventional

Bilateral transverse sinus stenosis (BTSS) is associated with intracranial hypertension (IH). However, not every BTSS patients presented with IH. The risk factors of IH in BTSS patients remained obscure. Vertebral venous collaterals (VVC) were often found in patients with bilateral transverse sinus stenosis (BTSS). The purpose of this study was to investigate the physiological role of VVC in BTSS patients.

NCT ID: NCT04492111 Completed - Clinical trials for Osseointegration Failure of Dental Implant

X-space Implants in Post-extraction Sites.

Start date: September 2, 2020
Phase: N/A
Study type: Interventional

Several recent systematic reviews have highlighted how the macrodesign of dental implants can influence stress distribution and biomechanical and biological behavior in implants immediately inserted in post-extraction sites. Finite element analyzes have confirmed the benefit of the inclination of the implant threads in reducing implant displacement in post-extraction sites, increasing primary stability, and decreasing stress in contact with the trabecular bone. Other comparative studies have shown that the design of the threads of the implant does not affect the distribution of stress in the surrounding bone. In view of the need to evaluate the influence of implant macrodesign in the case of implants inserted in post-extraction alveoli, this study will examine the clinical results of two different types of implants with different macrodesigns, with the aim of providing scientific evidence in this regard. The present study will investigate through a randomized controlled trial the effect of thread macrodesign of X-space implants on primary stability and osseointegration when inserted in post-extraction sites, as compared to cylindric 2P implants.

NCT ID: NCT04491890 Completed - Clinical trials for Cross-cultural Adaptation, Evaluation and Validation Study of Wang Qi's Constitution in TCM Questionnaire (For Old Person)

Cross-cultural Adaptation, Evaluation and Validation of Wang Qi's Constitution of TCM Questionnaire (For Old Person)

Start date: July 31, 2019
Phase:
Study type: Observational

This is a cross-cultural adaptation, evaluation and validation study of Wang Qi's Constitution in TCM questionnaire (For Old Person) in Hong Kong to investigate the content validity, construct validity and reliability of the CTCMQ-C in Cantonese speaking Hong Kong Chinese elderly population.

NCT ID: NCT04491877 Completed - Clinical trials for Respiratory Syncytial Virus Infection

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

VAD00001
Start date: September 17, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objectives of the study were: - To assess the safety profile of each dose of the study product after each and any administration in all infants and toddlers regardless of baseline serostatus. - To characterize the Respiratory Syncytial Virus (RSV) A serum neutralizing antibody responses to the study product in each vaccine group after vaccination in RSV-naïve participants. The secondary objectives of the study were: - To quantify the amount of vaccine virus shed by each participant by baseline serostatus. - To determine the proportion of vaccinated infants and toddlers in each vaccine group infected with the vaccine virus at D56 (56 days after vaccination 1) for Cohorts 1, 2, 3 and 4, and at Day 84 (28 days after vaccination 2) for Cohorts 2 and 4 by baseline serostatus. - To characterize the RSV A serum neutralizing antibody responses to the study product in each vaccine group after vaccination in RSV-experienced participants. - To characterize serum RSV anti-F immunoglobulin G (IgG) antibody responses to the study product in each vaccine group after vaccination by baseline serostatus. - To characterize serum RSV antibody responses (RSV A-neutralizing and anti-RSV F IgG) to the study product in each vaccine group after the RSV surveillance season or at least 5 months after the last vaccine administration by baseline serostatus.

NCT ID: NCT04491773 Completed - Clinical trials for Erectile Dysfunction Following Radical Prostatectomy

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months

Start date: November 1, 2019
Phase:
Study type: Observational

This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg for more than 6 months, using optical coherence tomography angiography.

NCT ID: NCT04491604 Completed - Clinical trials for Recessive Dystrophic Epidermolysis Bullosa

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

GEM-3
Start date: August 17, 2020
Phase: Phase 3
Study type: Interventional

To determine whether administration of topical B-VEC improves wound healing as compared to placebo, and to evaluate durability, repeat dosing (Primary Endpoint) and further obtain safety and tolerability data.